Tech Insider
Andrea Javor wearing glasses, a white t-shirt, and jeans sitting on the ground and smiling on the camera while leaning on a bed.
Andrea Javor started doing insulin shots in public.
Tech Insider
A blue eye.
Patients with NAION don't have enough blood flowing to their optic nerve.
Gizmodo

New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare condition that can cause blindness called nonarteritic anterior ischemic optic…

Read more...

Gizmodo

The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…

Read more...

Gizmodo

It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potential user wary: They don’t only help you lose weight—they supposedly…

Read more...

Gizmodo

Scientists in the U.K. seem to have unearthed yet another benefit of exercise: It could make our bodies better at using up certain kinds of fat. In a new study out this week, researchers found that endurance athletes were much better at burning off saturated fat compared to sedentary people with type 2 diabetes—a…

Read more...

Gizmodo

Results from the longest-running trial of semaglutide—the active ingredient in the popular drugs Ozempic and Wegovy—are in, and the verdict is decidedly positive. The study found that people taking semaglutide tended to maintain their initial weight loss for up to four years. Other trial data presented this week also…

Read more...

Gizmodo

At least 224 people have been injured after an iPhone app called t:connect drained the battery on its accompanying insulin pump, called t:slim X2, causing the pump to fail to deliver insulin. The FDA issued a Class I recall of the app on Wednesday, according to a press release, the most serious type of recall issued…

Read more...

Gizmodo

A constant feeling of strange tingling and numbness along a person’s legs might be much more common than assumed in some parts of the U.S., new research out Wednesday suggests. Researchers have found evidence that a substantial majority of older adults in Flint, Michigan are experiencing neuropathy, an uncomfortable…

Read more...